Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

36.87
-0.9100-2.41%
Post-market: 36.890.0200+0.05%19:59 EDT
Volume:2.50M
Turnover:92.77M
Market Cap:4.35B
PE:13.33
High:38.52
Open:37.68
Low:36.70
Close:37.78
52wk High:42.81
52wk Low:22.22
Shares:118.00M
Float Shares:109.00M
Volume Ratio:1.35
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-20.92
PE(LYR):22.48

Loading ...

Indivior CSO Christian Heidbreder Disposes of $764,432.04 in Common Shares

Reuters
·
Jul 14

Indivior Pharmaceuticals (INDV) Pushes Cost Cuts And Growth, Is It Still 17% Undervalued?

Simply Wall St.
·
Jun 26

Indivior Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jun 18

Indivior Pharmaceuticals, Inc :  Barclays Initiates Coverage With Overweight Rating and Target Price $46

THOMSON REUTERS
·
Jun 18

Barclays Initiates Indivior at Overweight With $46 Price Target

MT Newswires Live
·
Jun 18

Indivior initiated with an Overweight at Barclays

TIPRANKS
·
Jun 18

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Reuters
·
Jun 18

REFILE-FACTBOX-UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 16

Indivior Chief Scientific Officer Christian Heidbreder disposes of 18,586 shares for $707,779.16

Reuters
·
Jun 13

UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 12

Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million

Reuters
·
Jun 10

Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)

TIPRANKS
·
Jun 05

Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative

Simply Wall St.
·
May 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

Indivior study links monthly injectable buprenorphine adherence to lower opioid relapse risk

Reuters
·
May 20

Indivior’s Earnings Call Highlights SUBLOCADE-Driven Surge

TIPRANKS
·
May 20

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership

TIPRANKS
·
May 16

Indivior eliminates chief scientific officer role; Heidbreder departs end-2026

Reuters
·
May 16

Indivior Pharmaceuticals Inc - to Eliminate Chief Scientific Officer Position Effective June 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 16